A mix-and-match approach to Covid vaccines - using different brands of jab for first and second doses - gives good protection against the pandemic virus, a UK study has found.
The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by...